Masimo this week announced that its O3 Regional Oximetry received expanded FDA clearance. The expanded use covers monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin and deoxyhemoglobin in adult brains. O3 is also now indicated for use in both cerebral and somatic applications. The oximetry device uses […]
FDA clears Masimo index to better track ventilated patients
Masimo (NSDQ:MASI) announced today that it received FDA clearance for its PVi for fluid responsiveness indication in ventilated adult patients. PVi (pleth variability index) now has indication as a continuous, non-invasive, dynamic indicator of responsiveness in select populations of mechanically ventilated adult patients, as it measures dynamic changes in the perfusion index that occur during the […]
Masimo providing pulse oximeters to monitor NBA players
Masimo (NSDQ:MASI) announced today that it entered into a partnership with the National Basketball Association to become its official supplier of pulse oximetry. The NBA is scheduled to return to competitive play tonight after going through steps to maintain safety in a “bubble”-style camp in Orlando, Fla. with 22 teams in an effort to ensure safety […]
Masimo debuts patient-info platform
Masimo (NSDQ:MASI) this week launched its UniView: 60 Hospital Automation platform. The platform aggregates and displays pertinent patient information on a display outside of a patient’s room. It allows clinicians to familiarize themselves with each patient’s case at the hospital room door in 60 seconds or less before physically seeing a patient. The information included in […]
Masimo announces drug-free opioid-withdrawal device
Masimo (NSDQ:MASI) announced that it received FDA de novo classification for its Bridge neuromodulation-based opioid withdrawal device. Bridge uses neuromodulation to aid in reducing the symptoms associated with opioid withdrawal. Irvine, Calif.-based Masimo touts it as the first evidence-based, drug-free, non-surgical device of its kind. The wearable, single-patient-use, percutaneous neurostimulator fits behind the ear and applies […]
FDA clears Masimo respiration sensor
Masimo (NSDQ:MASI) announced today that its Centroid wireless orientation, activity and respiration rate sensor received FDA clearance. Centroid is a wearable sensor designed to monitor patient position in an effort to avoid preventable pressure ulcers, while also alerting clinicians to sudden movements, such as fall-like events. The device also detects chest movements to continuously provide respiration […]
Masimo launches monitoring for reopening economy
Masimo recently launched its SafetyNet-Open that is designed to businesses, governments and schools manage employee and student health and safety during the COVID-19 pandemic. The remote patient monitoring solution helps coordinate the continuous monitoring of people through sensors and an app. Its centralized dashboard helps organizations understand patterns that could support contact tracing. The components […]
Philips patient monitors to add more Masimo technology
Masimo (NSDQ:MASI) and Royal Philips (NYSE:PHG) announced today that Philips will integrate additional Masimo measurement technologies into certain IntelliVue MX-series monitors to help clinicians assess cerebral oximetry and ventilation status. Masimo noninvasive measurements, such as SET measure-through motion and Low Perfusion pulse oximetry and advanced rainbow SET Pulse CO-Oximetry parameters like noninvasive hemoglobin (SpHb), have long been […]
Masimo up on Street-beating 1Q
Masimo (NSDQ:MASI) shares inched up today on first-quarter results that topped the consensus forecast. The Irvine, Calif.-based company posted profits of $64 million, or $1.12 per share, on sales of $269.6 million for the three months ended March 28, 2020, for a 30.7% bottom-line gain on sales growth of 16.4%. Adjusted to exclude one-time items, earnings […]
Masimo withdraws 2020 guidance due to COVID-19
Masimo (NSDQ:MASI) announced today that it is updating its preliminary product revenue range for the first quarter but withdrawing its full-year 2020 guidance as a result of the COVID-19 pandemic. The Irvine, Calif.-based non-invasive monitoring technology developer anticipates product revenue in the first quarter of 2020 to range between $265 million and $271 million, reflecting growth […]
Masimo acquires TNI Medical
Non-invasive monitoring technology developer Masimo (NSDQ:MASI) announced that it plans to acquire German ventilation company TNI Medical for an undisclosed amount. Irvine, Calif.-based Masimo pulled the trigger on the acquisition after it disclosed an investment in August 2019 that included an exclusive option to purchase Würzburg, Germany-based TNI. Masimo expects to close the deal in the […]
- 1
- 2
- 3
- …
- 21
- Next Page »
